TY - JOUR
T1 - Laboratory workflow analysis of culture of periprosthetic tissues in blood culture bottles
AU - Peel, Trisha N.
AU - Sedarski, John A.
AU - Dylla, Brenda L.
AU - Shannon, Samantha K.
AU - Amirahmadi, Fazlollaah
AU - Hughes, John G.
AU - Cheng, Allen C.
AU - Patel, Robin
N1 - Funding Information:
R.P. reports grants from BioFire, Check-Points, Curetis, 3M, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company. R.P. is a consultant to Curetis, Roche, Qvella, and Diaxonhit. In addition, R.P. has a patent on a Bordetella pertussis/B. parapertussis PCR assay with royalties paid by TIB, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an antibiofilm substance issued. R.P. serves on an Actelion data monitoring board. R.P. receives travel reimbursement and an editor’s stipend from ASM and IDSA and honoraria from the USMLE, Up-to-Date, and the Infectious Diseases Board Review Course.
Funding Information:
T.N.P. was supported by the Richard Memorial Kemp Fellowship, Royal Australasian College of Physicians, and the National Health and Medical Research Council Medical Early Career Fellowship (APP1069734). A.C.C. was supported by a National Health and Medical Research Council Career Development Fellowship 2 (APP1068732). R.P. was supported by the National Institutes of Health (grants R01 AR056647 and R01 AI91594).
Publisher Copyright:
Copyright © 2017 American Society for Microbiology.
PY - 2017/9
Y1 - 2017/9
N2 - Culture of periprosthetic tissue specimens in blood culture bottles is more sensitive than conventional techniques, but the impact on laboratory workflow has yet to be addressed. Herein, we examined the impact of culture of periprosthetic tissues in blood culture bottles on laboratory workflow and cost. The workflow was process mapped, decision tree models were constructed using probabilities of positive and negative cultures drawn from our published study (T. N. Peel, B. L. Dylla, J. G. Hughes, D. T. Lynch, K. E. Greenwood-Quaintance, A. C. Cheng, J. N. Mandrekar, and R. Patel, mBio 7:e01776-15, 2016, https://doi.org/10.1128/mBio.01776-15), and the processing times and resource costs from the laboratory staff time viewpoint were used to compare periprosthetic tissues culture processes using conventional techniques with culture in blood culture bottles. Sensitivity analysis was performed using various rates of positive cultures. Annualized labor savings were estimated based on salary costs from the U.S. Labor Bureau for Laboratory staff. The model demonstrated a 60.1% reduction in mean total staff time with the adoption of tissue inoculation into blood culture bottles compared to conventional techniques (mean ± standard deviation, 30.7 ± 27.6 versus 77.0 ± 35.3 h per month, respectively; P < 0.001). The estimated annualized labor cost savings of culture using blood culture bottles was $10,876.83 (±$337.16). Sensitivity analysis was performed using various rates of culture positivity (5 to 50%). Culture in blood culture bottles was cost-effective, based on the estimated labor cost savings of $2,132.71 for each percent increase in test accuracy. In conclusion, culture of periprosthetic tissue in blood culture bottles is not only more accurate than but is also cost-saving compared to conventional culture methods.
AB - Culture of periprosthetic tissue specimens in blood culture bottles is more sensitive than conventional techniques, but the impact on laboratory workflow has yet to be addressed. Herein, we examined the impact of culture of periprosthetic tissues in blood culture bottles on laboratory workflow and cost. The workflow was process mapped, decision tree models were constructed using probabilities of positive and negative cultures drawn from our published study (T. N. Peel, B. L. Dylla, J. G. Hughes, D. T. Lynch, K. E. Greenwood-Quaintance, A. C. Cheng, J. N. Mandrekar, and R. Patel, mBio 7:e01776-15, 2016, https://doi.org/10.1128/mBio.01776-15), and the processing times and resource costs from the laboratory staff time viewpoint were used to compare periprosthetic tissues culture processes using conventional techniques with culture in blood culture bottles. Sensitivity analysis was performed using various rates of positive cultures. Annualized labor savings were estimated based on salary costs from the U.S. Labor Bureau for Laboratory staff. The model demonstrated a 60.1% reduction in mean total staff time with the adoption of tissue inoculation into blood culture bottles compared to conventional techniques (mean ± standard deviation, 30.7 ± 27.6 versus 77.0 ± 35.3 h per month, respectively; P < 0.001). The estimated annualized labor cost savings of culture using blood culture bottles was $10,876.83 (±$337.16). Sensitivity analysis was performed using various rates of culture positivity (5 to 50%). Culture in blood culture bottles was cost-effective, based on the estimated labor cost savings of $2,132.71 for each percent increase in test accuracy. In conclusion, culture of periprosthetic tissue in blood culture bottles is not only more accurate than but is also cost-saving compared to conventional culture methods.
KW - Diagnosis
KW - Laboratory costs
KW - Laboratory workflow
KW - Prosthetic joint infection
KW - Semiautomated
UR - http://www.scopus.com/inward/record.url?scp=85028299942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028299942&partnerID=8YFLogxK
U2 - 10.1128/JCM.00652-17
DO - 10.1128/JCM.00652-17
M3 - Article
C2 - 28701418
AN - SCOPUS:85028299942
SN - 0095-1137
VL - 55
SP - 2817
EP - 2826
JO - Journal of clinical microbiology
JF - Journal of clinical microbiology
IS - 9
ER -